JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB63995

Recombinant HIV1 p55 protein

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant HIV1 p55 protein is a HIV-1 M:B_ARV2/SF2 Full Length protein, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE.

View Alternative Names

Gag polyprotein, Pr55Gag, gag

2 Images
SDS-PAGE - Recombinant HIV1 p55 protein (AB63995)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant HIV1 p55 protein (AB63995)

Polyacrylamide gel electrophoresis of ab63995.
The arrows show degradation products.

SDS-PAGE - Recombinant HIV1 p55 protein (AB63995)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant HIV1 p55 protein (AB63995)

SDS-PAGE analysis of Recombinant HIV1 p55 protein. As the substrate, Recombinant HIV1 p55 protein (1 μg, ab63995) was used in 20 μl reaction volume. The reaction was carried by incubating at 37℃ for 3 h and stopped by adding SDS-PAGE sample buffer. Lane 1 : no protease,
Lane 2 : 0.16 pg.
Lane 3 : 1.6 pg.
Lane 4 : 16 pg
Lane 5 : 0.16 μg
Lane 6 : 1.6 μg protease.
Note that two degradation bands are observed in the preparation of p55 substrate. In lane 4, p25 band is visible and in lane 5, p13 band is visible.

Key facts

Purity

>90% SDS-PAGE

Expression system

Escherichia coli

Tags

Tag free

Applications

SDS-PAGE

applications

Biologically active

No

Accession

P03349

Animal free

No

Carrier free

No

Species

HIV-1 M:B_ARV2/SF2

Storage buffer

pH: 6 - 8.5 Constituents: 20% Glycerol (glycerin, glycerine), 0.316% Tris HCl, 0.29% Sodium chloride, 0.078% 2-Mercaptoethanol

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

ab63995 has been derived from infectious plasmid clone pNL4-3 and belongs to Group B of HIV-1.

Active as HIV-1 protease substrate

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P03349","tags":[]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The HIV-1 p55 protein also known as the Gag polyprotein serves mechanically as a precursor essential for virion assembly in HIV-1. This protein has a molecular mass of approximately 55 kDa and is expressed in host cells infected with the HIV-1 virus. It undergoes proteolytic cleavage by HIV-1 protease to produce matrix (MA) capsid (CA) nucleocapsid (NC) and p6 proteins. These smaller proteins are integral for the formation and maturation of the viral particle. The efficiency of this process impacts the production of infectious virions.
Biological function summary

The HIV-1 p55 protein plays a significant role in the structural integrity and replication cycle of the virus. This polyprotein is part of a larger complex involved in the intracellular assembly and release of viral particles. Its assembly process occurs predominantly at the plasma membrane of the host cell where p55 targets and orchestrates the encapsidation of the viral RNA and other proteins. By doing so it facilitates the budding and maturation of the virus which is critical for sustaining the infection process in the host.

Pathways

The HIV-1 p55 protein integrates into the HIV replication pathway where it interacts with host cell machinery to initiate viral assembly. The protein coordinates with other viral proteins like reverse transcriptase and integrase which are involved in the reverse transcription and integration of the viral genome. Additionally the p55 protein links to the ESCRT pathway a cellular pathway important for membrane fission events including virus budding. Through interactions with proteins such as Tsg101 the p55 protein navigates these host pathways to ensure successful viral replication and spread.

The HIV-1 p55 protein is directly linked to the pathogenesis of acquired immunodeficiency syndrome (AIDS). The efficient processing and functionality of p55 are pivotal for HIV-1 virulence. Disruption of p55 processing affects the production of viral particles impacting disease progression in HIV-infected individuals. The protein's activity also relates to mutations found in the HIV-1 protease a therapeutic target for antiretroviral drugs. These mutations can lead to drug resistance presenting challenges in managing HIV infection with existing therapies.

Specifications

Form

Liquid

Additional notes

Purified by several steps of chromatography

General info

Function

Gag polyprotein. Mediates, with Gag-Pol polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi).. Matrix protein p17. Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus (By similarity). Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA (By similarity).. Capsid protein p24. Forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion. Most core are conical, with only 7% tubular. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry (By similarity). The capsid promotes immune invasion by cloaking viral DNA from CGAS detection (By similarity). Host restriction factors such as TRIM5-alpha or TRIMCyp bind retroviral capsids and cause premature capsid disassembly, leading to blocks in reverse transcription. Capsid restriction by TRIM5 is one of the factors which restricts HIV-1 to the human species. Host PIN1 apparently facilitates the virion uncoating (By similarity). On the other hand, interactions with PDZD8 or CYPA stabilize the capsid (By similarity).. Nucleocapsid protein p7. Encapsulates and protects viral dimeric unspliced genomic RNA (gRNA). Binds these RNAs through its zinc fingers. Acts as a nucleic acid chaperone which is involved in rearangement of nucleic acid secondary structure during gRNA retrotranscription. Also facilitates template switch leading to recombination. As part of the polyprotein, participates in gRNA dimerization, packaging, tRNA incorporation and virion assembly.. p6-gag. Plays a role in budding of the assembled particle by interacting with the host class E VPS proteins TSG101 and PDCD6IP/AIP1.

Sequence similarities

Belongs to the primate lentivirus group gag polyprotein family.

Post-translational modifications

Gag-Pol polyprotein: Specific enzymatic cleavages by the viral protease yield mature proteins.. Matrix protein p17. Tyrosine phosphorylated presumably in the virion by a host kinase. Phosphorylation is apparently not a major regulator of membrane association.. Capsid protein p24 is phosphorylated possibly by host MAPK1; this phosphorylation is necessary for Pin1-mediated virion uncoating.. Nucleocapsid protein p7 is methylated by host PRMT6, impairing its function by reducing RNA annealing and the initiation of reverse transcription.

Subcellular localisation

Host endosome

Product protocols

Target data

Gag polyprotein. Mediates, with Gag-Pol polyprotein, the essential events in virion assembly, including binding the plasma membrane, making the protein-protein interactions necessary to create spherical particles, recruiting the viral Env proteins, and packaging the genomic RNA via direct interactions with the RNA packaging sequence (Psi).. Matrix protein p17. Targets the polyprotein to the plasma membrane via a multipartite membrane-binding signal, that includes its myristoylated N-terminus (By similarity). Matrix protein is part of the pre-integration complex. Implicated in the release from host cell mediated by Vpu. Binds to RNA (By similarity).. Capsid protein p24. Forms the conical core that encapsulates the genomic RNA-nucleocapsid complex in the virion. Most core are conical, with only 7% tubular. The core is constituted by capsid protein hexamer subunits. The core is disassembled soon after virion entry (By similarity). The capsid promotes immune invasion by cloaking viral DNA from CGAS detection (By similarity). Host restriction factors such as TRIM5-alpha or TRIMCyp bind retroviral capsids and cause premature capsid disassembly, leading to blocks in reverse transcription. Capsid restriction by TRIM5 is one of the factors which restricts HIV-1 to the human species. Host PIN1 apparently facilitates the virion uncoating (By similarity). On the other hand, interactions with PDZD8 or CYPA stabilize the capsid (By similarity).. Nucleocapsid protein p7. Encapsulates and protects viral dimeric unspliced genomic RNA (gRNA). Binds these RNAs through its zinc fingers. Acts as a nucleic acid chaperone which is involved in rearangement of nucleic acid secondary structure during gRNA retrotranscription. Also facilitates template switch leading to recombination. As part of the polyprotein, participates in gRNA dimerization, packaging, tRNA incorporation and virion assembly.. p6-gag. Plays a role in budding of the assembled particle by interacting with the host class E VPS proteins TSG101 and PDCD6IP/AIP1.
See full target information gag

Additional targets

HIV1 p55

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com